Improving nutrition products for Vietnamese children

Press release -

Improving nutrition products for Vietnamese children

At a ceremony in Zurich, Switzerland today Chr. Hansen and Vinamilk, a leading Vietnamese dairy corporation, officially signed an agreement formalizing a strategic cooperation on bioscience-based nutrition products for Vietnamese children.

The first result of the cooperation is a new nutrition product for children under the brand name “Dielac Pedia”. The infant formula product which will be launched in Vietnam shortly contains a blend of Chr. Hansen’s flagship probiotic strains BB-12® and LGG®.

“I am very pleased to have signed this cooperation agreement which will further develop our partnership with Vinamilk that has been working very well for years already,” comments Chr. Hansen’s Henrik Dalboege, Executive Vice President, Health & Nutrition Division. “We are already a trusted supplier of documented probiotics for Vinamilk’s nutrition products for children but I anticipate that this cooperation agreement will bring us even close together while working on our shared task: to develop nutritional products with proven health benefits for consumers, in this case Vietnamese children.”

“The unfulfilled nutritional needs of children differ from country to country, relying on various factors such as socio-economy and living habits. The thorough understanding of such needs is a good point of departure for Vinamilk to develop specific nutritional products for Vietnamese children”, says Mr. Nguyen Quoc Khanh, Executive Director of R&D and Production, Vinamilk. “Our strategic cooperation with Chr. Hansen will significantly support us in developing breakthrough products in world-class quality which fit the needs of Vietnamese children.”

Topics

Chr. Hansen is a global bioscience company that develops natural ingredient solutions for the food, nutritional, pharmaceutical and agricultural industries. The products include cultures, enzymes, probiotics and natural colors, and all solutions are based on strong research and development competencies coupled with significant technology investments. Revenue in the 2013/14 financial year was EUR 756 million. The company holds a leading market position in all its divisions: Cultures & Enzymes, Health & Nutrition and Natural Colors. It has more than 2,500 dedicated employees in over 30 countries and main production facilities in Denmark, France, USA and Germany. Chr. Hansen was founded in 1874 and is listed on NASDAQ OMX Copenhagen.

Contacts

Helle Rexen

Helle Rexen

Press contact Media relations officer +45 20 74 28 40

About us

Chr. Hansen is a global, differentiated bioscience company that develops natural ingredient solutions for the food, nutritional, pharmaceutical and agricultural industries. At Chr. Hansen we are uniquely positioned to drive positive change through microbial solutions. We have worked for over 150 years to enable sustainable agriculture, better food and healthier living for more people around the world. Our microbial and fermentation technology platforms, including our broad and relevant collection of around 50,000 microbial strains, have game-changing potential. Matching customer needs and global trends we continue to unlock the power of good bacteria to respond to global challenges such as food waste, global health and the overuse of antibiotics and pesticides. As one of the world’s most sustainable companies, we touch the lives of more than 1 billion people every day. Driven by our legacy of innovation and curiosity to pioneer science, our purpose – To grow a better world. Naturally. – is at the heart of everything we do.

Chr. Hansen Holding A/S

Boege Allé 10-12
DK-2970 Hoersholm
Denmark

Chr. Hansen website
Investor Relations
Read more about Chr. Hansen
Enter your email address to follow Chr. Hansen Holding A/S

When you choose to create a user account and follow a newsroom your personal data will be used by us and the owner of the newsroom, for you to receive news and updates according to your subscription settings.

To learn more about this, please read our Privacy Policy, which applies to our use of your personal data, and our Privacy Policy for Contacts, which applies to the use of your personal data by the owner of the newsroom you follow.

Please note that our Terms of Use apply to all use of our services.

You can withdraw your consent at any time by unsubscribing or deleting your account.
Check your inbox

Email sent to __email__. Click the link there to follow Chr. Hansen Holding A/S.

Okay